Page last updated: 2024-10-25

ci 994 and Atrial Remodeling

ci 994 has been researched along with Atrial Remodeling in 1 studies

tacedinaline: oral cytostatic drug with impressive differential activity against leukemic cells & normal stem-cells
tacedinaline : A benzamide obtained by formal condensation of the carboxy group of 4-acetamidobenzoic acid with one of the amino groups of 1,2-phenylenediamine. An oral cytostatic drug with impressive differential activity against leukemic cells and normal stem-cells. Also used in combination therapy for selected tumors including non-smoll cell lung, pancreatic, breast, and colorectal cancers.

Atrial Remodeling: Long-term changes in the electrophysiological parameters and/or anatomical structures of the HEART ATRIA that result from prolonged changes in atrial rate, often associated with ATRIAL FIBRILLATION or long periods of intense EXERCISE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seki, M1
LaCanna, R1
Powers, JC1
Vrakas, C1
Liu, F1
Berretta, R1
Chacko, G1
Holten, J1
Jadiya, P1
Wang, T1
Arkles, JS1
Copper, JM1
Houser, SR1
Huang, J1
Patel, VV1
Recchia, FA1

Other Studies

1 other study available for ci 994 and Atrial Remodeling

ArticleYear
Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation.
    The Journal of pharmacology and experimental therapeutics, 2016, Volume: 358, Issue:3

    Topics: Adipocytes; Animals; Atrial Fibrillation; Atrial Remodeling; B-Lymphocytes; Benzamides; Biomarkers;

2016